Stop Immoral Price Gouging for Lifesaving EpiPen
Millions of children and adults in the U.S. are at risk of fatal allergic reactions from common occurrences like getting stung by a bee or accidentally consuming peanuts.
A pocket-sized medical device called an EpiPen can be a literal lifesaver for these folks.
But Mylan — the multinational pharmaceutical company that makes the EpiPen — has been steadily jacking up the price.
- In 2007, the wholesale price on an EpiPen in the U.S. was $57.
- Today, just nine years later, it’s over $300.
- Even though each EpiPen contains only a few dollars’ worth of medicine.
- Even though a two-pack is just $85 in France.
- And even though Mylan, which has a near monopoly in the U.S., has seen its profits from the EpiPen alone skyrocket to $1.2 billion a year.
Now, many people who could actually die without an EpiPen can’t afford one!
Tell Mylan CEO Heather Bresch to Immediately Reduce the Price of This Life-and-Death Treatment that so Many People Depend On
Stop price gouging the millions of people who need an EpiPen to save their lives if they have a severe allergic reaction.